Evommune, Inc. (EVMN)
NYSE · Common · CUSIP 30054Y107
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for EVMN and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
30054Y107
Business: Evommune, Inc. is a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases.

Company Contact

CEO
Luis Peña
CFO
Kyle Carver
Headquarters
1841 Page Mill Road, Suite 100, Palo Alto, CA
Phone
925-247-4481
Investor Relations
Sarah McCabe · investors@evommune.com
SEC EDGAR Filings
View filings »